{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:10:26Z","timestamp":1772122226010,"version":"3.50.1"},"reference-count":40,"publisher":"Cambridge University Press (CUP)","issue":"12","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0033291720000847_sec_a1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>First episode psychosis (FEP) patients who use cannabis experience more frequent psychotic and euphoric intoxication experiences compared to controls. It is not clear whether this is consequent to patients being more vulnerable to the effects of cannabis use or to their heavier pattern of use. We aimed to determine whether extent of use predicted psychotic-like and euphoric intoxication experiences in patients and controls and whether this differs between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0033291720000847_sec_a2\" sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analysed data on patients who had ever used cannabis (\n                      <jats:italic>n<\/jats:italic>\n                      = 655) and controls who had ever used cannabis (\n                      <jats:italic>n<\/jats:italic>\n                      = 654) across 15 sites from six countries in the EU-GEI study (2010\u20132015). We used multiple regression to model predictors of cannabis-induced experiences and to determine if there was an interaction between caseness and extent of use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0033291720000847_sec_a3\" sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Caseness, frequency of cannabis use and money spent on cannabis predicted psychotic-like and euphoric experiences (\n                      <jats:italic>p<\/jats:italic>\n                      \u2a7d 0.001). For psychotic-like experiences (PEs) there was a significant interaction for caseness \u00d7 frequency of use (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) and caseness \u00d7 money spent on cannabis (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001) such that FEP patients had increased experiences at increased levels of use compared to controls. There was no significant interaction for euphoric experiences (\n                      <jats:italic>p<\/jats:italic>\n                      &gt; 0.5).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0033291720000847_sec_a4\" sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FEP patients are particularly sensitive to increased psychotic-like, but not euphoric experiences, at higher levels of cannabis use compared to controls. This suggests a specific psychotomimetic response in FEP patients related to heavy cannabis use. Clinicians should enquire regarding cannabis related PEs and advise that lower levels of cannabis use are associated with less frequent PEs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s0033291720000847","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T02:46:45Z","timestamp":1588042005000},"page":"2074-2082","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":7,"title":["Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls"],"prefix":"10.1017","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4420-8618","authenticated-orcid":false,"given":"Musa","family":"Sami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Quattrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Tripoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika La","family":"Cascia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Gayer-Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Selten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Tarricone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tortelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusy","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"del Peschio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Marta","family":"Del-Ben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart P.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"van Os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieuwe","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathryn","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagnik","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom P.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lynskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Di","family":"Forti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"S0033291720000847_ref40","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.1580"},{"key":"S0033291720000847_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(19)30056-8"},{"key":"S0033291720000847_ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000092678"},{"key":"S0033291720000847_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.01.048"},{"key":"S0033291720000847_ref5","first-page":"6315","article-title":"Psychotic symptoms following oxycodone withdrawal, case report and update","volume":"23","author":"Casado-Espada","year":"2019","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"S0033291720000847_ref4","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291715002494"},{"key":"S0033291720000847_ref7","doi-asserted-by":"publisher","DOI":"10.1017\/S003329171800226X"},{"key":"S0033291720000847_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30048-3"},{"key":"S0033291720000847_ref18","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw003"},{"key":"S0033291720000847_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61162-3"},{"key":"S0033291720000847_ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291707002619"},{"key":"S0033291720000847_ref23","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415599846"},{"key":"S0033291720000847_ref16","first-page":"36","volume":"75","author":"Jongsma","year":"2018","journal-title":"Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study"},{"key":"S0033291720000847_ref36","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291714000117"},{"key":"S0033291720000847_ref39","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11cr07608"},{"key":"S0033291720000847_ref30","first-page":"1","article-title":"Psychotic-like experiences with cannabis use predict cannabis cessation and desire to quit: A cannabis discontinuation hypothesis","volume":"49","author":"Sami","year":"2018","journal-title":"Psychological Medicine"},{"key":"S0033291720000847_ref13","doi-asserted-by":"publisher","DOI":"10.1111\/add.12634"},{"key":"S0033291720000847_ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000236906"},{"key":"S0033291720000847_ref31","first-page":"1","article-title":"Effects of continuation, frequency and type of cannabis use on relapse in the first two years following onset of psychosis \u2013 an observational study","volume":"366","author":"Schoeler","year":"2016","journal-title":"The Lancet. Psychiatry"},{"key":"S0033291720000847_ref24","doi-asserted-by":"publisher","DOI":"10.1177\/0020764018801690"},{"key":"S0033291720000847_ref38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbu069","article-title":"Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations","volume":"40","author":"Van Os","year":"2014","journal-title":"Schizophrenia Bulletin"},{"key":"S0033291720000847_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(14)00117-5"},{"key":"S0033291720000847_ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.329"},{"key":"S0033291720000847_ref33","doi-asserted-by":"publisher","DOI":"10.1159\/000155215"},{"key":"S0033291720000847_ref26","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033401"},{"key":"S0033291720000847_ref20","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.219"},{"key":"S0033291720000847_ref14","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20629"},{"key":"S0033291720000847_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.07.070"},{"key":"S0033291720000847_ref12","volume-title":"European drug report trends and developments 2016","year":"2016"},{"key":"S0033291720000847_ref37","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291708003814"},{"key":"S0033291720000847_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.12.006"},{"key":"S0033291720000847_ref21","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291709005522"},{"key":"S0033291720000847_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.02.005"},{"key":"S0033291720000847_ref32","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291701005141"},{"key":"S0033291720000847_ref25","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a007116"},{"key":"S0033291720000847_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2011.06.012"},{"key":"S0033291720000847_ref6","doi-asserted-by":"publisher","DOI":"10.1038\/npjschz.2015.25"},{"key":"S0033291720000847_ref15","article-title":"Cannabis use and psychosis: A review of reviews","author":"Hasan","year":"2019","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"S0033291720000847_ref34","doi-asserted-by":"publisher","DOI":"10.1111\/add.13645"},{"key":"S0033291720000847_ref29","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2013.824330"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291720000847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T10:13:40Z","timestamp":1643019220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291720000847\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0033291720000847"],"URL":"https:\/\/doi.org\/10.1017\/s0033291720000847","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/739425","asserted-by":"object"}]},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2020. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}